comparemela.com

Nuno Mendon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AC Immune Announces Upcoming Presentations at AD/PD™ 2024

AC Immune Announces Upcoming Presentations at AD/PD™ 2024 Multiple presentations at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2024)Andrea Pfeifer, Ph.D., CEO to lead AC Immune-sponsored symposium on alpha-synuclein pathologies Lausanne, Switzerland, February 22, 2024 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced upcoming presentations highlighting its preci

AC Immune SA: AC Immune Announces Upcoming Presentations at AD/PD 2024

AC Immune SA: AC Immune Announces Upcoming Presentations at AD/PD 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

AC Immune SA: AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

AC Immune SA: AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update

04.08.2023 - AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update Received FDA Fast Track Designation for ACI-24.060 anti-amyloid-beta (Abeta) active immunotherapy to treat Alzheimer’s disease (AD)Enrollment in ongoing Phase .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.